搜尋結果
2021年10月29日 · MERISLON TAB 6MG Registration No.: HK-48603 Certificate Holder: EISAI (HONG KONG) CO LTD Certificate Holder Address:
Merislon. betahistine. / Concise Prescribing Info. Contents. Betahistine mesilate. Indications/Uses. Vertigo & dizziness associated w/ Meniere's syndrome; Meniere's disease, & peripheral vertigo. Click to view Merislon detailed prescribing information. Dosage/Direction for Use. 1-2 tab (6-12 mg) tds.
2022年11月7日 · For Print. November 7, 2022. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has entered into an agreement to divest its rights for muscle relaxant Myonal ® (generic name: eperisone hydrochloride) and vertigo and equilibrium disturbance treatment Merislon ® (generic name: betahistine ...
藥品簡介. 本品是一個組織胺類似物。. 劑量資訊. 治療梅尼艾氏症，劑量為一天3次，每次8~16mg。. 藥物動力學. 口服後1小時達到最高血中濃度，大部分由肝臟代謝，半衰期為3.5小時。. 可能副作用. 很少有噁心、嘔吐 及發疹等過敏症狀。. 臨床用途.
2022年2月28日 · Kenny Cheuk Yin Cheung, Pharmacist. Last Updated: 2022-02-28. What is Merislon for? Merislon is a brand product that contains Betahistine, which is a type of histamine analogue. It has a range of actions on multiple histamine receptors. Merislon is used to treat vertigo and tinnitus. How to use it? Merislon is available as tablets.
眩暈可能肇因於中樞神經疾病或周邊的末梢神經問題，要達到良好的治療有賴正確的診斷，有了診斷後才能對症下藥。 治療眩暈症狀的藥品主要可分為抗組織胺類、抗膽鹼類、止吐藥與鎮靜劑。 抗組織胺類藥品可以抑制組織胺釋放，減少末端神經的敏感性，故有助於治療眩暈；尤其是第一代的抗組織胺由於同時有抗膽鹼作用，對於眩暈的治療效果較佳…。 關鍵字：治療眩暈,眩暈,眩暈藥物,抗組織胺,抗膽鹼,止吐藥,鎮靜劑.
2024年4月18日 · Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA Mar 29, 2024 14:51 HKT/SGT Eisai to Divest Rights for Merislon
